Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

• Giandomenico Roviello,
• Sebastiano Buti,
• Carlo Cattrini,
• Alessia Mennitto,
• Carlo Messina,
• Chiara Airoldi,
• Gianmarco Vannini,
• Melissa Bersanelli

Affiliations

Giandomenico Roviello

Sebastiano Buti

Carlo Cattrini

Alessia Mennitto

Carlo Messina

Chiara Airoldi

Gianmarco Vannini

Melissa Bersanelli